Richard A. Kayne, 10% Owner at Eiger BioPharmaceuticals, Inc. (EIGR), bought 278,239 shares at $0.28 ($73K) on 2023-11-01, disclosed to the SEC on 2023-11-02.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.24 | 130,509 | $31K | 43.1% |
| 2 | $0.26 | 11,987 | $3K | 4.3% |
| 3 | $0.26 | 12,345 | $3K | 4.4% |
| 4 | $0.28 | 100,000 | $28K | 38.5% |
| 5 | $0.30 | 23,398 | $7K | 9.7% |
| Total | $0.26 avg | 278,239 |
| $73K |
| 100% |
| Filing → |
| KMF | SELL | 2018-10-04 | $260K | — | Filing → |
| KED | BUY | 2018-08-01 | $35K | — | Filing → |
| KYN | BUY | 2018-05-08 | $250K | — | Filing → |